Anyone have Email Addresses for Foxnews anchors, CNBC

New Post Public Reply Private Reply Replies (5) Message Board
the lawman
691
Anyone have Email Addresses for Foxnews anchors, CNBC anchors, and anyone else you can think should who should be contacted, this would be much appreciated.

Here was the email I sent today to the people whose email I was able to find:

Leronlimab, a late state drug developed by American pharmaceutical company Cytodyn, is BY FAR the most effective drug for treating COVID-19 patients.

Cytodyn today announced a patient at a leading Southern California hospital, who was treated for 4 days on other drugs, but ended up on life support, came off of life support, and is now healed, withing days after being treated with Leronlimab.

Two of the other Socal CV patients were removed from oxygen soon after who being administered Leronlimab.

4 out of 9 seriously ill Covid-19 patients who were treated with Leronlimab at a leading New York City hospital, were able to be taken off of their ventilators after only three days.

The immune function in all 9 of these seriously ill Covid-19 patients was fully restored after 7 days, while their cytokine storms were reduced between 70 and 90 percent.

The patients who improved greatly on Leronlimab had previously been treated, without success, on either hydroxychloride or remdesivir.

In other words, these 9 patients had better results after being treated with Leronlimab than they had after being treated with either hydroxychloride or remdesivir.

In over 800 patients who have been treated with Leronlimab for HIV and metastatic breast cancer over the past five years, there has not been one serious adverse event attributable to this drug.

In other words, other than some pain at the injection site--and the injection is only subcutaneous, the same as an insulin injection--there are virtually no side effects from Leronlimab.

Leronlimab is now in two FDA approved clinical trials for mild to moderate, and seriously ill, Covid-19 patients.

Cytodyn expects to have at least some results from these trials within 30 days.

For the good of the country, Leronlimab should be the treatment of choice for both mild to moderate and seriously ill CV patients.

Thank you.

LM

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
The Lawman[img]
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 0

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
Rethinking Roof Lifespans for Harsh Michigan Winters

Updated Category News Views 0

Unraveling the Michigan Roof Lifespan Myth When most folks think about the lifespan of their roof, especially in a place like Michigan, they tend to believe those thirty-year warranties plastered all over asphalt shingles. But that's the fairy tale version, folks. Tom Meadows, a roofing expert from Ann Arbor, wants residents to wake up to a chilling reality—Michigan's...

Continue Reading
Rice University's Explosive Growth Story: 2026 Outlook

Updated Category News Views 2

Charting a Path to New Heights Who would've thought a small campus in Houston could make waves this big? Rice University, the underdog rising through the ranks, is kicking off a historic growth phase. With application numbers through the roof and a flood of new students on campus, it's time to peek behind the curtain and see what this means for the institution that's...

Continue Reading
How Shelton's Property Taxes Influence Housing Costs

Updated Category News Views 2

Thinking about snapping up a home in Shelton, Connecticut? Well, you might want to keep an eye on those property taxes first. Sure, mortgage rates and listing prices grab all the initial attention, but taxes—oh boy, they know how to creep up on ya. Matt Nuzie from RE/MAX lays it bare: property taxes can make or break the bank for homebuyers in Fairfield County. So,...

Continue Reading
BNI Sets Sights on Big Expansion Across Europe

Updated Category News Views 2

BNI Charges Forward: Europe Expansion Strategy This one's got me thinking about how networking giants like BNI are not sitting back comfortably, they're on the move. BNI is going all-in on Europe, making serious waves by locking down new franchise territories in France, Italy, and the UK. It's no small feat—they already have a footprint there with over 35,000 members...

Continue Reading
ONTO Faces Fiduciary Duty Investigation Alert

Updated Category News Views 2

Possible Fiduciary Abuses at Onto Innovation Imagine you’re cruising down the investment highway when, bam, an alert like this pops up in your rearview mirror. It’s time to hit the brakes and figure out what Levi & Korsinsky is up to with this investigation into Onto Innovation Inc. (NYSE: ONTO). They're sniffing around possible breaches of fiduciary duties by some of...

Continue Reading
Mech-Mind Robotics Debuts on HKEX: A Game Changer

Updated Category News Views 3

Mech-Mind Robotics has been strutting its stuff on the Hong Kong Stock Exchange, stepping right onto the stage with a market cap that tips the scales at a hefty HK$12.71 billion. Not every day you see a fresh face in the AI space commanding that kind of attention, but when you dig into the details, well, maybe it isn't all that surprising after all. A Strategic Player in...

Continue Reading
Claroty Earns Top Marks in OT Security Evaluation

Updated Category News Views 4

A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...

Continue Reading
Quandri Joins Applied Systems Certification for AI Edge

Updated Category News Views 1

Quandri Steps Into the Limelight with Vendor Certification Alright, so you’ve got Quandri, an up-and-coming player on the insurance tech scene, making some hefty strides by snatching a coveted spot in Applied Systems' brand new Vendor Certification Program. Yeah, it sounds like another day at the software club, but what this really means is less runaround and more...

Continue Reading
Ignyte Insurance Acquires InsureMyTrip to Expand Portfolio

Updated Category News Views 1

Key Acquisition: Strengthening Global Presence Ignyte Insurance just added a major player to its roster with the acquisition of InsureMyTrip. No two ways about it, this move is about expanding their footprint in the booming travel and medical insurance sector. Now, if you've ever thought travel insurance was just fine print nobody reads, think again. This industry’s got...

Continue Reading

Top 5 Most Recently Viewed Articles

ONEOK Completes Strategic Medallion Midstream Acquisition

Updated Category News Views 130

ONEOK Completes Strategic Medallion Midstream Acquisition The journey towards enhanced energy infrastructure continues as ONEOK, Inc. (NYSE: OKE) has successfully finalized its acquisition of Medallion Midstream from Global Infrastructure Partners. With this monumental transaction valued at approximately $2.6 billion, ONEOK adds a pivotal asset to its growing portfolio....

Continue Reading
Stolen Sculptures by Sir Daniel Winn Worth Millions

Updated Category News Views 209

High-Profile Theft: Two Major Sculptures Stolen Renowned Artist and Airport Art Commissioner Targeted in Sophisticated Heist This week, an incredible theft took place, marking a stunning incident for the art community. Two monumental sculptures by well-known artist Sir Daniel Winn, valued together at more than $2.15 million, were stolen from a secure facility. Local...

Continue Reading
UniFirst Corporation: Analyst Insights and Earnings Outlook

Updated Category News Views 107

Overview of UniFirst Corporation UniFirst Corporation (NYSE: UNF) is poised to release its earnings results for the first quarter soon. As analysts prepare for this significant milestone, there are noteworthy changes in forecasts that are shaping expectations for the company. The release of earnings will occur before the market opens, and many are eager to see how well...

Continue Reading
Alstom Invests Over €150 Million to Boost Production Capacity

Updated Category News Views 346

Alstom's Major Investment to Enhance Production in France Alstom is making significant strides toward strengthening its production capabilities in France with an investment plan exceeding €150 million. This initiative aims to address the upsurge in demand for rail transportation, especially for very high-speed trains. The automotive and rail industries have seen vast...

Continue Reading
International Money Express Secures $425 Million Credit Facility

Updated Category News Views 71

International Money Express, Inc. Secures $425 Million Credit Facility International Money Express, Inc. (NASDAQ: IMXI), a prominent omni-channel money remittance company, has successfully refinanced its existing secured debt by establishing a new revolving credit facility worth $425 million. This new credit agreement allows for loans in U.S. Dollars, Euros, and Pound...

Continue Reading